Medical countermeasures and other therapeutic strategies for sulfur mustard toxicity

Handbook of Toxicology of Chemical Warfare Agents

Volumn , Issue , 2009, Pages 897-918

  Vijayaraghavan, R ^a   Gautam, Anshoo ^a   Sharma, Manoj ^a  

^a DEFENCE RESEARCH AND DEVELOPMENT ESTABLISHMENT   (India)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 77956276295     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012374484-5.00060-2     Document Type: Chapter

References (189)

1. Amir A., Chapman S., Gozes Y., Sahar R., Allon N. Protection by extracellular glutathione against sulfur mustard induced toxicity in vitro. Hum. Exp. Toxicol. 1998, 17:652-660.
2. Amir, A., Turetz, J., Chapman, S., Fishbeine, E., Meshulam, J., Sahar, R., Liani, H., Gilat, E., Frishman, G., Kadar, T. (2000a). Beneficial effects of topical anti-inflammatory drugs against sulfur mustard-induced ocular lesions in rabbits. J. Appl. Toxicol.20: S109-14.
3. Amir, A., Chapman, S., Kadar, T., Gozes, Y., Sahar, R., Allon, N. (2000b). Sulfur mustard toxicity in macrophages: effect of dexamethasone. J. Appl. Toxicol.20: S51-8.
4. Amitai G., Adani R., Fishbein E., Meshulam H., Laish I., Dachir S. Bifunctional compounds eliciting anti-inflammatory and anti-cholinesterase activity as potential treatment of nerve and blister chemical agents poisoning. Chem. Biol. Interact. 2005, 157-8:361-362.
5. Amitai G., Adani R., Fishbein E., Meshulam H., Laish I., Dachir S. Bifunctional compounds eliciting anti-inflammatory and anti-cholinesterase activity as potential treatment of nerve and blister chemical agents poisoning. J. Appl. Toxicol. 2006, 26:81-87.
6. Anderson D.R., Byers S.L., Vesely K.R. Treatment of sulfur mustard (HD)-induced lung injury. J. Appl. Toxicol. 2000, 20:129-132.
7. Anderson D.R., Holmes W.W., Lee R.B., Dalal S.J., Hurst C.G., Maliner B.I., Newmark J., Smith W.J. Sulfur mustard-induced neutropenia: treatment with granulocyte colony-stimulating factor. Mil. Med. 2006, 171:448-453.
8. Andrew, D.J., Lindsay, C.D. (1998a). Protection of human upper respiratory tract cell lines against sulphur mustard toxicity by hexamethylenetetramine (HMT). Hum. Exp. Toxicol.17: 373-9.
9. Andrew, D.J., Lindsay, C.D. (1998b). Protection of human upper respiratory tract cell lines against sulphur mustard toxicity by glutathione esters. Hum. Exp. Toxicol.17: 387-95.
10. Arfsten D.P., Johnson E.W., Wilfong E.R., Jung A.E., Bobb A.J. Distribution of radio-labeled N-acetyl-L-cysteine in Sprague-Dawley rats and its effect on glutathione metabolism following single and repeat dosing by oral gavage. Cutan. Ocul. Toxicol. 2007, 26:113-134.
11. Atkins K.B., Lodhi I.J., Hurley L.L., Hinshaw D.B. N-acetylcysteine and endothelial cell injury by sulfur mustard. J. Appl. Toxicol. 2000, 20:S125-S128.
12. Babin M.C., Ricketts K., Skvorak J.P., Gazaway M., Mitcheltree L.W., Casillas R.P. Systemic administration of candidate antivesicants to protect against topically applied sulfur mustard in the mouse ear vesicant model (MEVM). J. Appl. Toxicol. 2000, 20:S141-S144.
13. Balali-Mood M., Hefazi M. The pharmacology, toxicology, and medical treatment of sulphur mustard poisoning. Fundam. Clin. Pharmacol. 2005, 19:297-315.
14. Balali-Mood M., Hefazi M. Comparison of early and late toxic effects of sulfur mustard in Iranian veterans. Basic Clin. Pharmacol. Toxicol. 2006, 99:273-282.
15. Balali-Mood M., Hefazi M., Mahmoudi M., Jalali E., Attaran D., Maleki M., Razavi M.E., Zare G., Tabatabaee A., Jafari M.R. Long-term complications of sulphur mustard poisoning in severely intoxicated Iranian veterans. Fundam. Clin. Pharmacol. 2005, 19:713-721.
16. Bhat K.R., Benton B.J., Rosenthal D.S., Smulson M.E., Ray R. Role of poly(ADP-ribose) polymerase (PARP) in DNA repair in sulfur mustard-exposed normal human epidermal keratinocytes (NHEK). J. Appl. Toxicol. 2000, 20:S13-S17.
17. Bhat K.R., Benton B.J., Ray R. Poly (ADP-ribose) polymerase (PARP) is essential for sulfur mustard-induced DNA damage repair, but has no role in DNA ligase activation. J. Appl. Toxicol. 2006, 26:452-457.
18. Bhattacharya R., Lakshmana Rao P.V., Pant S.C., Kumar Pravin, Tulsawani R.K., Pathak U., Kulkarni A., Vijayaraghavan R. Protective effects of amifostine and its analogues on sulfur mustard toxicity in vitro and. in vivo. Toxicol. Appl. Pharmacol. 2001, 176:24-33.
19. Blaha, M., Bowers, W., Jr., Kohl, J., DuBose, D., Walker, J. (2000a). IL-1-related cytokine responses of nonimmune skin cells subjected to CEES exposure with and without potential vesicant antagonists. In Vitro Mol. Toxicol.13: 99-111.
20. Blaha, M., Bowers, W., Jr., Kohl, J., DuBose, D., Walker, J., Alkhyyat, A., Wong, G. (2000b). Effects of CEES on inflammatory mediators, heat shock protein 70A, histology and ultrastructure in two skin models. J. Appl. Toxicol.20: S101-8.
21. Bobb A.J., Arfsten D.P., Jederberg W.W. N-Acetyl-L-cysteine as prophylaxis against sulfur mustard. Mil. Med. 2005, 170:52-56.
22. Borak J., Sidell F.R. Agents of chemical warfare: sulfur mustard. Ann. Emerg. Med. 1992, 21:303-308.
23. Brodsky B., Wormser U. Protection from toxicants. Curr. Probl. Dermatol. 2007, 34:76-86.
24. Brodsky B., Trivedi S., Peddada S., Flagler N., Wormser U., Nyska A. Early effects of iodine on DNA synthesis in sulfur mustard-induced skin lesions. Arch. Toxicol. 2006, 80:212-216.
25. Buczyński A., Gnitecki W. Effect of mustard gas on supraoxide dismutase activity and the level of malonyl dialdehyde: in vitro studies. Int. J. Occup. Med. Environ. Health 1999, 12:119-122.
26. Cai Y., Ma Q., Zhang L., Zhao J., Zhu M., Hu W., Jiang P., Yuan W. Therapeutic effects of rhEPO, rhG-CSF on sulfur mustard induced toxicity in dogs. Wei Sheng Yan Jiu 2004, 33:649-651.
27. Callaway S., Pearce K.A. Protection against systemic poisoning by mustard gas di (2-chloroethyl) sulfide by sodium thiosulphate and thiocit in the albino rat. Br. J. Pharmacol. 1958, 13:395-398.
28. Calvet, J.H., D'Ortho, M.P., Jarreau, P.H., Levame, M., Harf, A., Macquin-Mavier, I. (1994a). Glucocorticoids inhibit sulfur mustard-induced airway muscle hyperresponsiveness to substance P. J. Appl. Physiol.77: 2325-32.
29. Calvet, J.H., Jarreau, P.H., Levame, M., D'Ortho, M.P., Lorino, H., Harf, A., Macquin-Mavier, I. (1994b). Acute and chronic respiratory effects of sulfur mustard intoxication in guinea pig. J. Appl. Physiol.76: 681-8.
30. Calvet J.H., Coste A., Levame M., Harf A., Macquin-Mavier I., Escudier E. Airway epithelial damage induced by sulfur mustard in guinea pigs, effects of glucocorticoids. Hum. Exp. Toxicol. 1996, 15:964-971.
31. Casbohm S.L., Rogers J.V., Stonerock M.K., Martin J.L., Ricketts-Kaminsky K.M., Babin M.C., Casillas R.P., Sabourin C.L. Localization of substance P gene expression for evaluating protective countermeasures against sulfur mustard. Toxicology 2004, 204:229-239.
32. Casillas R.P., Kiser R.C., Truxall J.A., Singer A.W., Shumaker S.M., Niemuth N.A., Ricketts K.M., Mitcheltree L.W., Castrejon L.R., Blank J.A. Therapeutic approaches to dermatotoxicity by sulfur mustard. I. Modulaton of sulfur mustard-induced cutaneous injury in the mouse ear vesicant model. J. Appl. Toxicol. 2000, 20:S145-S151.
33. Cerny L.C., Cerny E.R. The effect of biological media on the hydrolysis of mustard simulants. Biomed. Sci. Instrum. 1997, 33:535-540.
34. Chatterjee D., Mukherjee S., Smith M.G., Das S.K. Signal transduction events in lung injury induced by 2-chloroethyl ethyl sulfide, a mustard analog. J. Biochem. Mol. Toxicol. 2003, 17:114-121.
35. Chatterjee D., Mukherjee S., Smith M.G., Das S.K. Evidence of hair loss after subacute exposure to 2-chloroethyl ethyl sulfide, a mustard analog, and beneficial effects of N-acetyl cysteine. J. Biochem. Mol. Toxicol. 2004, 18:150-153.
36. Chilcott R.P., Jenner J., Hotchkiss S.A., Rice P. In vitro skin absorption and decontamination of sulphur mustard: comparison of human and pig-ear skin. J. Appl. Toxicol. 2001, 21:279-283.
37. Chilcott R.P., Jenner J., Hotchkiss S.A., Rice P. Evaluation of barrier creams against sulphur mustard. I. In vitro studies using human skin. Skin Pharmacol. Appl. Skin Physiol. 2002, 15:225-235.
38. Chilcott R.P., Dalton C.H., Ashley Z., Allen C.E., Bradley S.T., Maidment M.P., Jenner J., Brown R.F., Gwyther R.J., Rice P. Evaluation of barrier creams against sulphur mustard: (II) in vivo and in vitro studies using the domestic white pig. Cutan. Ocul. Toxicol. 2007, 26:235-247.
39. Clark C.R., Smith J.R., Shih M.L. Development of an in vitro screening method for evaluating decontamination of sulfur mustard by reactive dermal formulations. J. Appl. Toxicol. 1999, 19:S77-S81.
40. Clayson E.T., Kelly S.A., Meier H.L. Effects of specific inhibitors of cellular functions on sulfur mustard-induced cell death. Cell Biol. Toxicol. 1993, 9:165-175.
41. Cowan F.M., Broomfield C.A., Smith W.J. Suppression of sulfur mustard-increased IL-8 in human keratinocyte cell cultures by serine protease inhibitors: implications for toxicity and medical countermeasures. Cell Biol. Toxicol. 2002, 18:175-180.
42. Cowan F.M., Broomfield C.A., Lenz D.E., Smith W.J. Putative role of proteolysis and inflammatory response in the toxicity of nerve and blister chemical warfare agents: implications for multi-threat medical countermeasures. J. Appl. Toxicol. 2003, 23:177-186.
43. Dabrowska M.I., Becks L.L., Lelli J.L., Levee M.G., Hinshaw D.B. Sulfur mustard induces apoptosis and necrosis in endothelial cells. Toxicol. Appl. Pharmacol. 1996, 141:568-583.
44. Dachir S., Fishbeine E., Meshulam Y., Sahar R., Amir A., Kadar T. Potential anti-inflammatory treatments against cutaneous sulfur mustard injury using the mouse ear vesicant model. Hum. Exp. Toxicol. 2002, 21:197-203.
45. Dachir S., Fishbeine E., Meshulam Y., Sahar R., Chapman S., Amir A., Kadar T. Amelioration of sulfur mustard skin injury following a topical treatment with a mixture of a steroid and a NSAID. J. Appl. Toxicol. 2004, 24:107-113.
46. Dacre J.C., Goldman M. Toxicology and pharmacology of the chemical warfare agent sulfur mustard. Pharmacol. Rev. 1996, 48:289-326.
47. Das S.K., Mukherjee S., Smith M.G., Chatterjee D. Prophylactic protection by N-acetylcysteine against the pulmonary injury induced by 2-chloroethyl ethyl sulfide, a mustard analogue. J. Biochem. Mol. Toxicol. 2003, 17:177-184.
48. Dillman J.F., McGary K.L., Schlager J.J. An inhibitor of p38 MAP kinase downregulates cytokine release induced by sulfur mustard exposure in human epidermal keratinocytes. Toxicol. Vitro 2004, 18:593-599.
49. Dillman J.F., Hege A.I., Phillips C.S., Orzolek L.D., Sylvester A.J., Bossone C., Henemyre-Harris C., Kiser R.C., Choi Y.W., Schlager J.J., Sabourin C.L. Microarray analysis of mouse ear tissue exposed to bis-(2-chloroethyl) sulfide: gene expression profiles correlate with treatment efficacy and an established clinical endpoint. J. Pharmacol. Exp. Ther. 2006, 317:76-87.
50. Dubey D.K., Malhotra R.C., Vaidyanathaswamy R., Vijayaraghavan R. Reaction of bis(2-chloroethyl) sulfide with N, N0-dichlorobis (2,4,6-trichlorophenyl) urea. J. Org. Chem. 1999, 64:8031-8033.
51. Ebtekar M., Hassan Z.M. Effect of immunomodulators pyrimethamine and cimetidine on immunosuppression induced by sulfur mustard in mice. Int. J. Immunopharmacol. 1993, 15:533-541.
52. Eldad, A., Ben Meir, P., Breiterman, S., Chaouat, M., Shafran, A., Ben-Bassat, H. (1998a). Superoxide dismutase (SOD) for mustard gas burns. Burns24: 114-19.
53. Eldad, A., Weinberg, A., Breiterman, S., Chaouat, M., Palanker, D., Ben-Bassat, H. (1998b). Early nonsurgical removal of chemically injured tissue enhances wound healing in partial thickness burns. Burns24: 166-72.
54. Emad, A., Emad, Y. (2007a). Comparison of bronchial responsiveness to ultrasonically nebulized distilled water (UNDW), methacholine, and ultrasonically nebulized distilled cold water (UDCW) in patients with sulfur mustard gas-induced asthma. Clin. Toxicol.45: 565-70.
55. Emad, A., Emad, Y. (2007b). Relationship between airway reactivity induced by methacholine or ultrasonically nebulized distilled cold water and BAL fluid cellular constituents in patients with sulfur mustard gas-induced asthma. J. Aerosol Med.20: 342-51.
56. Evison D., Brown R.F., Rice P. The treatment of sulphur mustard burns with laser debridement. J. Plast. Reconstr. Aesthet. Surg. 2006, 59:1087-1093.
57. Gao X., Ray R., Xiao Y., Barker P.E., Ray P. Inhibition of sulfur mustard-induced cytotoxicity and inflammation by the macrolide antibiotic roxithromycin in human respiratory epithelial cells. BMC Cell Biol. 2007, 8:17.
58. Gautam A., Vijayaraghavan R. The prophylactic effect of gossypin against percutaneously administered sulfur mustard. Biomed. Environ. Sci. 2007, 20:250-259.
59. Gautam A., Singh S., Kulkarni A.S., Pant S.C., Vijayaraghavan R. Protective effect of Aloe vera L. gel against sulphur mustard induced systemic toxicity and skin lesions. Indian J. Pharmacol. 2005, 37:103-110.
60. Gautam A., Vijayaraghavan R., Sharma M., Ganesan K. Comparative toxicity studies of sulfur mustard (2,20-dichloro diethyl sulfide) and monofunctional sulfur mustard (2-chloroethyl ethyl sulfide), administered through various routes in mice. J. Med. Chem. Biol. Rad. Def. 2006, 4:e1-20.
61. Gautam A., Vijayaraghavan R., Pant S.C., Kumar O., Singh S., Satish Kumar H.T. Protective effect of quercetin against sulphur mustard induced oxidative stress in mice. Def. Sci. J. 2007, 57:707-720.
62. Geraci M.J. imminent danger or eminent threat?. Ann. Pharmacother. 2008, 42:237-246. Mustard gas.
63. Ghanei M. Delayed haematological complications of mustard gas. J. Appl. Toxicol. 2004, 24:493-495.
64. Ghanei M., Khalili A.R., Arab M.J., Mojtahedzadeh M., Aslani J., Lessan-Pezeshki M., Panahi Y., Alaeddini F. Diagnostic and therapeutic value of short-term corticosteroid therapy in exacerbation of mustard gas-induced chronic bronchitis. Basic Clin. Pharmacol. Toxicol. 2005, 97:302-305.
65. Ghanei M., Shohrati M., Harandi A.A., Eshraghi M., Aslani J., Alaeddini F., Manzoori H. Inhaled corticosteroids and long-acting beta 2-agonists in treatment of patients with chronic bronchiolitis following exposure to sulfur mustard. Inhal. Toxicol. 2007, 19:889-894.
66. Gold M.B., Bongiovanni R., Scharf B.A., Gresham V.C., Woodward C.L. Hypochlorite solution as a decontaminant in sulfur mustard contaminated skin defects in the euthymic hairless guinea pig. Drug Chem. Toxicol. 1994, 17:499-527.
67. Graham, J.S., Schomacker, K.T, Glatter, R.D., Briscoe, C.M., Braue, E.H., Jr., Squibb, K.S. (2002a). Efficacy of laser debridement with autologous split-thickness skin grafting in promoting improved healing of deep cutaneous sulfur mustard burns. Burns28: 719-30.
68. Graham, J.S., Schomacker, K.T., Glatter, R.D., Briscoe, C.M., Braue, E.H., Jr., Squibb, K.S. (2002b). Bioengineering methods employed in the study of wound healing of sulphur mustard burns. Skin Res. Technol.8: 57-69.
69. Graham J.S., Chilcott R.P., Rice P., Milner S.M., Hurst C.G., Maliner B.I. Wound healing of cutaneous sulfur mustard injuries: strategies for the development of improved therapies. J. Burns Wounds 2005, 4: e1.
70. Graham J.S., Stevenson R.S., Mitcheltree L.W., Simon M., Hamilton T.A., Deckert R.R., Lee R.B. Improved wound healing of cutaneous sulfur mustard injuries in a weanling pig. J. Burns Wounds 2006, 5: e7.
71. Grando S.A. Mucocutaneous cholinergic system is targeted in mustard-induced vesication. Life Sci. 2003, 72:2135-2144.
72. Gross C.L., Innace J.K., Hovatter R.C., Meier H.L., Smith W.J. Biochemical manipulation of intracellular glutathione levels influences cytotoxicity to isolated human lymphocytes by sulfur mustard. Cell Biol. Toxicol. 1993, 9:259-267.
73. Gross C.L., Giles K.C., Smith W.J. L-oxothiazolidine 4-carboxylate pretreatment of isolated human peripheral blood lymphocytes reduces sulfur mustard cytotoxicity. Cell Biol. Toxicol. 1997, 13:167-173.
74. Gross C.L., Nealley E.W., Nipwoda M.T., Smith W.J. Pretreatment of human epidermal keratinocytes with D, L-sulforaphane protects against sulfur mustard cytotoxicity. Cutan. Ocul. Toxicol. 2006, 25:155-163.
75. Guignabert, C., Taysse, L., Calvet, J.H., Planus, E., Delamanche, S., Galiacy, S., d'Ortho, M.P. (2005). Effect of doxycycline on sulfur mustard-induced respiratory lesions in guinea pigs. Am. J. Physiol. Lung. Cell. Mol. Physiol.289: L67-74.
76. Han S., Espinoza L.A., Liao H., Boulares A.H., Smulson M.E. Protection by antioxidants against toxicity and apoptosis induced by the sulphur mustard analogue 2-chloroethylethyl sulphide (CEES) in Jurkat T cells and normal human lymphocytes. Br. J. Pharmacol. 2004, 141:795-802.
77. Hinshaw D.B., Lodhi I.J., Hurley L.L., Atkins K.B., Dabrowska M.I. Activation of poly [ADP-ribose] polymerase in endothelial cells and keratinocytes: role in an in vitro model of sulfur mustard-mediated vesication. Toxicol. Appl. Pharmacol. 1999, 156:17-29.
78. Hur G.H., Kim Y.B., Choi D.S., Kim J.H., Shin S. Apoptosis as a mechanism of 2-chloroethylethyl sulfide-induced cytotoxicity. Chem. Biol. Interact. 1998, 110:57-70.
79. Illig L., Paul E., Eyer P., Weger N., Born W. Treatment of psoriasis vulgaris with external sulfur mustard gas with particular reference to its potential carcinogenic risk. III. Clinical and experimental studies on the extent of percutaneous and inhalational uptake of sulfur mustard gas. Z. Hautkr. 1979, 54:941-951.
80. Ishida H., Ray R., Ray P. Sulfur mustard downregulates iNOS expression to inhibit wound healing in a human keratinocyte model. J. Dermatol. Sci. 2008, 49:207-216.
81. Jafari M. Dose-and time-dependent effects of sulfur mustard on antioxidant system in liver and brain of rat. Toxicology 2007, 231:30-39.
82. Janouchek B., Horakova M., Bartak P. Treatment of psoriasis with dichlorodiethyl sulfide. Phlebologie 1987, 40:171-175.
83. Jin X., Ray R., Leng Y., Ray P. Molecular determination of laminin-5 degradation: a biomarker for mustard gas exposure diagnosis and its mechanism of action. Exp. Dermatol. 2008, 17:49-56.
84. Johnson R.P., Hill C.L. Polyoxometalate oxidation of chemical warfare agent simulants in fluorinated media. J. Appl. Toxicol. 1999, 19:S71-S75.
85. Kadar T., Fishbeine E., Meshulam Y., Sahar R., Chapman S., Liani H., Barness I., Amir A. Treatment of skin injuries induced by sulfur mustard with calmodulin antagonists, using the pig model. J. Appl. Toxicol. 2000, 20:S133-S136.
86. Kadar T., Turetz J., Fishbine E., Sahar R., Chapman S., Amir A. Characterization of acute and delayed ocular lesions induced by sulfur mustard in rabbits. Curr. Eye Res. 2001, 22:42-53.
87. Kadar T., Fishbeine E., Meshulam J., Sahar R., Amir A., Barness I. A topical skin protectant against chemical warfare agents. Isr. Med. Assoc. J. 2003, 5:717-719.
88. Kehe K., Szinicz L. Medical aspects of sulphur mustard poisoning. Toxicology 2005, 214:198-209.
89. Kehe K., Raithel K., Kreppel H., Jochum M., Worek F., Thiermann H. Inhibition of poly(ADP-ribose) polymerase (PARP) influences the mode of sulfur mustard (SM)-induced cell death in HaCaT cells. Arch. Toxicol. 2007, 82:461-470.
90. Kim, Y.B., Hur, G.H., Choi, D.S., Shin, S., Han, B.G, Lee, Y.S., Sok, D.E. (1996a). Effects of calmodulin antagonists and anesthetics on the skin lesions induced by 2-chloroethylethyl sulfide. Eur. J. Pharmacol.313: 107-14.
91. Kim, Y.B., Lee, Y.S., Choi, D.S., Cha, S.H., Sok, D.E. (1996b). Change in glutathione S-transferase and glyceraldehyde-3-phosphate dehydrogenase activities in the organs of mice treated with 2-chloroethyl ethyl sulfide or its oxidation products. Food Chem. Toxicol.34: 259-65.
92. Knezević D.L., Tadić V. Radioprotective agents in the decontamination of rats poisoned with percutaneously administered mustard gas. Vojnosanit Pregl. 1996, 53:373-376.
93. Koper O., Lucas E., Klabunde K.J. Development of reactive topical skin protectants against sulfur mustard and nerve agents. J. Appl. Toxicol. 1999, 19:S59-S70.
94. Korkmaz A., Yaren H., Topal T., Oter S. Molecular targets against mustard toxicity: implication of cell surface receptors, peroxynitrite production, and PARP activation. Arch. Toxicol. 2006, 80:662-670.
95. Kulkarni A.S., Vijayaraghavan R., Gautam A., Pathak U., Raza S.K., Pant S.C., Malhotra R.C., Prakash A.O. Evaluation of analogues of DRDE-07 as prophylactic agents against the lethality and toxicity of sulfur mustard administered through percutaneous route. J. Appl. Toxicol. 2006, 26:115-125.
96. Kumar O., Sugendran K., Vijayaraghavan R. Protective effect of various antioxidants on the toxicity of sulphur mustard administered to mice by inhalation or percutaneous routes. Chem. Biol. Interact. 2001, 134:1-12.
97. Kumar P., Sharma U.S., Vijayaraghavan R. Study of the efficacy of CC-2 and Fuller's earth combination as a decontaminant against sulphur mustard (mustard gas) dermal intoxication in mice. Def. Sci. J. 1991, 41:363-366.
98. Kumar P., Vijayaraghavan R., Kulkarni A.S., Pathak U., Raza S.K., Jaiswal D.K. In vivo protection by amifostine and DRDE-07 against mustard toxicity. Hum. Exp. Toxicol 2002, 21:371-376.
99. Lakshmana Rao, P.V., Vijayaraghavan, R., Bhaskar, A.S.B. (1999). Sulphur mustard induced DNA damage in mice after dermal and inhalation exposure. Toxicology139: 39-51.
100. Lal J., Kumar V., Gupta R.C. LC determination of a sulphur mustard decontaminant CC-2 in rat serum. J. Pharm. Biomed. Anal. 2002, 29:609-615.
101. Lindsay C.D., Hambrook J.L. Protection of A549 cells against the toxic effects of sulphur mustard by hexamethylenetetramine. Hum. Exp. Toxicol. 1997, 16:106-114.
102. Lindsay C.D., Hambrook J.L. Diisopropylglutathione ester protects A549 cells from the cytotoxic effects of sulphur mustard. Hum. Exp. Toxicol. 1998, 17:606-612.
103. Lindsay C.D., Hambrook J.L., Lailey A.F. Monoisopropylglutathione ester protects A549 cells from the cytotoxic effects of sulphur mustard. Hum. Exp. Toxicol. 1997, 16:636-644.
104. Lindsay C.D., Gentilhomme E., Mathieu J.D. The use of doxycycline as a protectant against sulphur mustard in HaCaT cells. J. Appl. Toxicol. 2007, 28:665-673.
105. Margulis A., Chaouat M., Ben-Bassat H., Eldad A., Icekson M., Breiterman S., Neuman R. Comparison of topical iodine and silver sulfadiazine as therapies against sulfur mustard burns in a pig model. Wound Repair Regen. 2007, 15:916-921.
106. Martínez-Moreno P., Nieto-Cerón S., Ruiz-Espejo F., Torres-Lanzas J., Tovar-Zapata I., Martínez-Hernández P., Vidal C.J., Cabezas-Herrera J. Acetylcholinesterase biogenesis is impaired in lung cancer tissues. Chem. Biol. Interact. 2005, 157-8:359-361.
107. Mazumder P.K., Sugendran K., Vijayaraghavan R. Protective efficacy of calcium channel blockers in sulphur mustard poisoning. Biomed. Environ. Sci. 1998, 11:363-369.
108. McClintock S.D., Till G.O., Smith M.G., Ward P.A. Protection from half-mustard-gas-induced acute lung injury in the rat. J. Appl. Toxicol. 2002, 22:257-262.
109. McClintock S.D., Hoesel L.M., Das S.K., Till G.O., NeffT., Kunkel R.G., Smith M.G., Ward P.A. Attenuation of half sulfur mustard gas-induced acute lung injury in rats. J. Appl. Toxicol. 2006, 26:126-131.
110. Meier H.L. The time-dependent effect of 2,20-dichlorodiethyl sulfide (sulfur mustard, HD, 1,10-thiobis [2-chloroethane]) on the lymphocyte viability and the kinetics of protection by poly(ADP-ribose) polymerase inhibitors. Cell. Biol. Toxicol. 1996, 12:147-153.
111. Meier H.L., Johnson J.B. The determination and prevention of cytotoxic effects induced in human lymphocytes by the alkylating agent 2,20-dichlorodiethyl sulfide (sulfur mustard, HD). Toxicol. Appl. Pharmacol. 1992, 113:234-239.
112. Meier H.L., Millard C.B. Alterations in human lymphocyte DNA caused by sulfur mustard can be mitigated by selective inhibitors of poly(ADP-ribose) polymerase. Biochim. Biophys. Acta 1998, 1404:367-376.
113. Meier H.L., Millard C., Moser J. Poly(ADP-ribose) polymerase inhibitors regulate the mechanism of sulfur mustard-initiated cell death in human lymphocytes. J. Appl. Toxicol. 2000, 20:S93-100.
114. Mérat S., Perez J.P., Rüttimann M., Bordier E., Lienhard A., Lenoir B., Pats B. Acute poisoning by chemical warfare agent: sulfur mustard. Ann. Fr. Anesth. Reanim. 2003, 22:108-118.
115. Mi L., Gong W., Nelson P., Martin L., Sawyer T.W. Hypothermia reduces sulphur mustard toxicity. Toxicol. Appl. Pharmacol. 2003, 193:73-83.
116. Minsavage G.D., Dillman J.F. Bifunctional alkylating agent-induced p53 and nonclassical nuclear factor kappaB responses and cell death are altered by caffeic acid phenethyl ester: a potential role for antioxidant/electrophilic response-element signaling. J. Pharmacol. Exp. Ther. 2007, 321:202-212.
117. Munro N.B., Watson A.P., Ambrose K.R., Griffin G.D. Treating exposure to chemical warfare agents: implications for health care providers and community emergency planning. Environ. Health Perspect. 1990, 89:205-215.
118. Naghii M.R. Sulfur mustard intoxication, oxidative stress, and antioxidants. Mil. Med. 2002, 167:573-575.
119. Nyska A., Lomnitski L., Maronpot R., Moomaw C., Brodsky B., Sintov A., Wormser U. Effects of iodine on inducible nitric oxide synthase and cyclooxygenase-2 expression in sulfur mustard-induced skin. Arch. Toxicol. 2001, 74:768-774.
120. Panahi Y., Ghanei M., Aslani J., Mojtahedzadeh M. The therapeutic effect of gamma interferon in chronic bronchiolitis due to mustard gas. Research Center for Chemical Injuries. Iran J. Allergy Asthma Immunol. 2005, 4:83-90.
121. Panahi Y., Davoodi S.M., Khalili H., Dashti-Khavidaki S., Bigdeli M. Phenol and menthol in the treatment of chronic skin lesions following mustard gas exposure. Singapore Med. J. 2007, 48:392-395.
122. Pant S.C., Vijayaraghavan R. Histomorphological and histochemical alterations following short-term inhalation exposure to sulfur mustard on visceral organs of mice. Biomed. Environ. Sci. 1999, 12:201-213.
123. Pant S.C., Vijayaraghavan R., Kannan G.M., Ganesan K. Sulfur mustard induced oxidative stress and its prevention by sodium 2,3-dimercaptopropane sulfonic acid (DMPS) in mice. Biomed. Environ. Sci. 2000, 13:225-232.
124. Pant S.C., Vijayaraghavan R. Histochemical and histomorphological alterations in the lungs of mice following acute sulfur mustard inhalation. J. Burns 2002, 1:6-15.
125. Papirmeister B., Gross C.L., Meier H.L., Petrali J.P., Johnson J.B. Molecular basis for mustard-induced vesication. Fundam. Appl. Toxicol. 1985, 5:S134-S149.
126. Paromov V., Suntres Z., Smith M., Stone W.L. Sulfur mustard toxicity following dermal exposure: role of oxidative stress, and antioxidant therapy. J. Burns Wounds 2007, 7:7.
127. Pathak U., Raza S.K., Kulkarni A.S., Vijayaraghavan R., Kumar P., Jiaswal D.K. Novel S-substituted aminoalkylamino ethanethiols: potential antidotes against sulfur mustard toxicity. J. Med. Chem 2004, 47:3817-3822.
128. Petrali J.P., Oglesby S.B., Meier H.L. Ultrastructural correlates of the protection afforded by niacinamide against sulfur mustard-induced cytotoxicity of human lymphocytes in vitro. Ultrastruct. Pathol. 1990, 14:253-262.
129. Popiel S., Witkiewicz Z., Nalepa T. The reactions of sulfur mustard with the active components of organic decontaminants. J. Hazard. Mater. 2005, 123:269-280.
130. Rappeneau S., Baeza-Squiban A., Marano F., Calvet J. Efficient protection of human bronchial epithelial cells against sulfur and nitrogen mustard cytotoxicity using drug combinations. Toxicol. Sci. 2000, 58:153-160.
131. Ray P., Chakrabarti A.K., Broomfield C.A., Ray R. Sulfur mustard-stimulated protease: a target for antivesicant drugs. J. Appl. Toxicol. 2002, 22:139-140.
132. Ray R., Legere R.H., Majerus B.J., Petrali J.P. Sulfur mustard-induced increase in intracellular free calcium level and arachidonic acid release from cell membrane. Toxicol. Appl. Pharmacol. 1995, 131:44-52.
133. Ray R., Benton B.J., Anderson D.R., Byers S.L., Petrali J.P. Intervention of sulfur mustard toxicity by downregulation of cell proliferation and metabolic rates. J. Appl. Toxicol. 2000, 20:S87-S91.
134. Reddy P.M.K., Dubey D.K., Kumar Pravin, Vijayaraghavan R. Evaluation of CC-2 as a decontaminant at various time intervals against topically applied sulphur mustard in mice. Indian J. Pharmacol. 1996, 28:227-231.
135. Rice P., Brown R.F., Lam D.G., Chilcott R.P., Bennett N.J. Dermabrasion -a novel concept in the surgical management of sulphur mustard injuries. Burns 2000, 26:34-40.
136. Ricketts K.M., Santai C.T., France J.A., Graziosi A.M., Doyel T.D., Gazaway M.Y., Casillas R.P. Inflammatory cytokine response in sulfur mustard-exposed mouse skin. J. Appl. Toxicol. 2000, 20:S73-S76.
137. Rosenthal D.S., Simbulan-Rosenthal C.M., Iyer S., Smith W.J., Ray R., Smulson M.E. Calmodulin, poly(ADP-ribose)polymerase and p53 are targets for modulating the effects of sulfur mustard. J. Appl. Toxicol. 2000, 20:S43-S49.
138. Sabourin C.L., Danne M.M., Buxton K.L., Casillas R.P., Schlager J.J. Cytokine, chemokine, and matrix metalloproteinase response after sulfur mustard injury to weanling pig skin. J. Biochem. Mol. Toxicol. 2002, 16:263-272.
139. Sabourin C.L., Rogers J.V., Choi Y.W., Kiser R.C., Casillas R.P., Babin M.C., Schlager J.J. Time-and dose-dependent analysis of gene expression using microarrays in sulfur mustard-exposed mice. J. Biochem. Mol. Toxicol. 2004, 18:300-312.
140. Safarinejad M.R., Moosavi S.A., Montazeri B. Ocular injuries caused by mustard gas: diagnosis, treatment, and medical defense. Mil. Med. 2001, 166:67-70.
141. Saladi R.N., Smith E., Persaud A.N. Mustard: a potential agent of chemical warfare and terrorism. Clin. Exp. Dermatol. 2006, 31:1-5.
142. Sawyer, T.W. (1998a). Characterization of the protective effects of L-nitroarginine methyl ester (L-NAME) against the toxicity of sulphur mustard in vitro. Toxicology131: 21-32.
143. Sawyer, T.W. (1998b). Modulation of sulfur mustard toxicity by arginine analogues and related nitric oxide synthase inhibitors in vitro. Toxicol. Sci.46: 112-23.
144. Sawyer T.W., Hamilton M.G. Effect of intracellular calcium modulation on sulfur mustard cytotoxicity in cultured human neonatal keratinocytes. Toxicol. Vitro 2000, 14:149-157.
145. Sawyer T.W., Risk D. Effects of selected arginine analogues on sulphur mustard toxicity in human and hairless guinea pig skin keratinocytes. Toxicol. Appl. Pharmacol. 2000, 163:75-85.
146. Sawyer T.W., Lundy P.M., Weiss M.T. Protective effect of an inhibitor of nitric oxide synthase on sulphur mustard toxicity in vitro. Toxicol. Appl. Pharmacol. 1996, 141:138-144.
147. Sawyer T.W., Hancock J.R., D'Agostino P.A. L-thiocitrulline: a potent protective agent against the toxicity of sulphur mustard in vitro. Toxicol. Appl. Pharmacol. 1998, 151:340-346.
148. Sawyer T.W., Nelson P., Hill I., Conley J.D., Blohm K., Davidson C., Sawyer T.W. Therapeutic effects of cooling swine skin exposed to sulfur mustard. Mil. Med. 2002, 167:939-943.
149. Sawyer, T.W., Vair, C., Nelson, P., Shei, Y., Bjarnason, S., Tenn, C., McWilliams, M., Villanueva, M., Burczyk, A. (2007). pH-dependent toxicity of sulphur mustard in vitro. Toxicol. Appl. Pharmacol.221: 363-71.
150. Shih, M.L., Korte, W.D., Smith, J.R., Szafraniec, L.L. (1999a). Analysis and stability of the candidate sulfur mustard decontaminant S-330. J. Appl. Toxicol.19: S89-95.
151. Shih, M.L., Korte, W.D., Smith, J.R., Szafraniec, L.L. (1999b). Reactions of sulfides with S-330, a potential decontaminant of sulfur mustard in formulations. J. Appl. Toxicol.19: S83-8.
152. Shohrati, M., Davoudi, M., Almasi, M., Sadr, B., Peyman, M. (2007a). Comparative study of Unna's Boot and betamethasone cream in the treatment of sulfur mustard-related pruritus. Cutan. Ocul. Toxicol.26: 303-9.
153. Shohrati, M., Davoudi, S.M., Keshavarz, S., Sadr, B., Tajik, A. (2007b). Cetirizine, doxepine, and hydroxyzine in the treatment of pruritus due to sulfur mustard: a randomized clinical trial. Cutan. Ocul. Toxicol.26: 249-55.
154. Shohrati, M., Tajik, A., Harandi, A.A., Davoodi, S.M., Akmasi, M. (2007c). Comparison of hydroxyzine and doxepin in treatment of pruritus due to sulfur mustard. Skinmed.6: 70-2.
155. Shohrati M., Aslani J., Eshraghi M., Alaedini F., Ghanei M. Therapeutics effect of N-acetyl cysteine on mustard gas exposed patients: evaluating clinical aspect in patients with impaired pulmonary function test. Respir. Med. 2008, 102:443-448.
156. Simbulan-Rosenthal C.M., Ray R., Benton B., Soeda E., Daher A., Anderson D., Smith W.J., Rosenthal D.S. Calmodulin mediates sulfur mustard toxicity in human keratinocytes. Toxicology 2006, 227:21-35.
157. Simpson R., Lindsay C.D. Effect of sulphur mustard on human skin cell lines with differential agent sensitivity. J. Appl. Toxicol. 2005, 25:115-128.
158. Smith, C.N., Lindsay, C.D. (2001a). Kojic acid reduces the cytotoxic effects of sulfur mustard on cultures containing human melanoma cells in vitro. J. Appl. Toxicol.21: 435-40.
159. Smith, C.N., Lindsay, C.D. (2001b). Stimulation of C32 and G361 melanoma cells using oleoyl acetyl glycerol and its effect on sulphur mustard cytotoxicity. Hum. Exp. Toxicol.20: 418-25.
160. Smith, C.N., Lindsay, C.D., Upshall, D.G. (1997). Presence of methenamine/glutathione mixtures reduces the cytotoxic effect of sulphur mustard on cultured SVK-14 human keratinocytes in vitro. Hum. Exp. Toxicol.16: 247-53.
161. Smith W.J., Gross C.L. Sulfur mustard medical countermeasures in a nuclear environment. Mil. Med. 2002, 167:101-102.
162. Somani S.M., Babu S.R. Toxicodynamics of sulfur mustard. Int. J. Clin. Pharmacol. Ther. Toxicol. 1989, 27:419-435.
163. Sourdeval M., Lemaire C., Deniaud A., Taysse L., Daulon S., Breton P., Brenner C., Boisvieux-Ulrich E., Marano F. Inhibition of caspase-dependent mitochondrial permeability transition protects airway epithelial cells against mustard-induced apoptosis. Apoptosis 2006, 11:1545-1559.
164. Steinritz D., Emmler J., Hintz M., Worek F., Kreppel H., Szinicz L., Kehe K. Apoptosis in sulfur mustard treated A549 cell cultures. Life Sci. 2007, 80:2199-2201.
165. Sugendran K., Kumar P., Vijayaraghavan R. Treatment of sulfur mustard poisoning. Def. Sci. J. 1998, 48:155-162.
166. Szinicz L., Worek F., Thiermann H., Kehe K., Eckert S., Eyer P. Development of antidotes: problems and strategies. Toxicology 2007, 233:23-30.
167. Taysse L., Daulon S., Delamanche S., Bellier B., Breton P. Skin decontamination of mustards and organophosphates: comparative efficiency of RSDL and Fuller's earth in domestic swine. Hum. Exp. Toxicol. 2007, 26:135-141.
168. Van Helden H.P., Kuijpers W.C., Diemel R.V. Asthma like symptoms following intratracheal exposure of guinea pigs to sulfur mustard aerosol: therapeutic efficacy of exogenous lung surfactant curosurf and salbutamol. Inhal. Toxicol. 2004, 16:537-548.
169. Vijayaraghavan R. Modifications of breathing pattern induced by inhaled sulphur mustard in mice. Arch. Toxicol 1997, 71:157-164.
170. Vijayaraghavan R., Sugendran K., Pant S.C., Husain K., Malhotra R.C. Dermal intoxication of mice with bis (2-chloroethyl) sulfide and the protective effect of flavonoids. Toxicology 1991, 69:35-42.
171. Vijayaraghavan, R., Kumar, P., Joshi, U., Raza, S.K., Lakshmana Rao, P.V., Malhotra, R.C., Jaiswal, D.K. (2001a). Prophylactic efficacy of amifostine and its analogues against sulphur mustard toxicity. Toxicology163: 83-91.
172. Vijayaraghavan, R., Kumar, P., Dubey, D.K., Ram Singh. (2001b). Evaluation of CC2 as a decontaminant in various hydrophilic and lipophilic formulations against sulphur mustard. Biomed. Environ. Sci.15: 25-35.
173. Vijayaraghavan R., Kumar P., Dubey D.K., Singh Ram, Sachan A.S., Kumar Deo, Sugendran K., Kumar Om, Singh M., Pant S.C., Bhattacharya R. Acute toxicity studies of CC2: an effective chemical decontaminant of sulphur mustard in hydrophilic formulation. Ind. J. Pharmacol. 2002, 34:321-331.
174. Vijayaraghavan R., Kulkarni A., Pant S.C., Kumar P., Rao P.V., Gupta N., Gautam A., Ganesan K. Differential toxicity of sulfur mustard administered through percutaneous, subcutaneous, and oral routes. Toxicol. Appl. Pharmacol. 2005, 202:180-188.
175. Vijayaraghavan R., Gautam A., Kumar O., Pant S.C., Sharma M., Singh S., Satish Kumar H.T., Singh A.K., Nivsarkar M., Kaushik M.P., Sawhney R.C., Chaurasia O.P., Prasad G.B.K.S. The protective effect of ethanolic and water extracts of sea buckthorn (Hippophae rhamnoides L.) against the toxic effects of mustard gas. Indian J. Exp. Biol. 2006, 44:821-831.
176. Vijayaraghavan R., Gautam A., Sharma M., Satish H.T., Pant S.C., Ganesan K. Comparative evaluation of some flavonoids and tocopherol acetate against the systemic toxicity of sulphur mustard. Indian J. Pharmacol. 2008, 40:114-120.
177. Vojvodić V., Milosavljević Z., Bosković B., Bojanić N. The protective effect of different drugs in rats poisoned by sulfur and nitrogen mustards. Fundam. Appl. Toxicol. 1985, 5:S160-S168.
178. Wagner G.W., Sorrick D.C., Procell L.R., Brickhouse M.D., Mcvey I.F., Schwartz L.I. Decontamination of VX, GD, and HD on a surface using modified vaporized hydrogen peroxide. Langmuir 2007, 23:1178-1186.
179. Wormser U., Nyska A. Protective effect of O-phenanthroline against mechlorethamine toxicity in the rat liver slice system and in the guinea pig skin. Arch. Toxicol. 1991, 65:666-670.
180. Wormser U., Brodsky B., Green B.S., Arad-Yellin R., Nyska A. Protective effect of povidone-iodine ointment against skin lesions induced by sulphur and nitrogen mustards and by non-mustard vesicants. Arch. Toxicol. 1997, 71:165-170.
181. Wormser, U., Brodsky, B., Green, B.S., Arad-Yellin, R., Nyska, A. (2000a). Protective effect of povidone iodine ointment against skin lesions induced by chemical and thermal stimuli. J. Appl. Toxicol.20: S183-5.
182. Wormser, U., Sintov, A., Brodsky, B., Nyska, A. (2000b). Topical iodine preparation as therapy against sulfur mustard-induced skin lesions. Toxicol. Appl. Pharmacol.169: 33-9.
183. Wormser, U., Brodsky, B., Reich, R. (2002a). Topical treatment with povidone iodine reduces nitrogen mustard-induced skin collagenolytic activity. Arch. Toxicol.76: 119-21.
184. Wormser, U., Brodsky, B., Sintov, A. (2002b). Skin toxicokinetics of mustard gas in the guinea pig: effect of hypochlorite and safety aspects. Arch. Toxicol.76: 517-22.
185. Wormser U., Sintov A., Brodsky B., Casillas R.P., Nyska A. Protective effect of topical iodine containing anti-inflammatory drugs against sulfur mustard-induced skin lesions. Arch. Toxicol. 2004, 78:156-166.
186. Wormser U., Brodsky B., Proscura E., Foley J.F., Jones T., Nyska A. Involvement of tumor necrosis factor-alpha in sulfur mustard-induced skin lesion; effect of topical iodine. Arch. Toxicol. 2005, 79:660-670.
187. Yourick J.J., Clark C.R., Mitcheltree L.W. Niacinamide pretreatment reduces microvesicle formation in hairless guinea pigs cutaneously exposed to sulfur mustard. Fundam. Appl. Toxicol. 1991, 17:533-542.
188. Yourick J.J., Dawson J.S., Mitcheltree L.W. Sulfur mustard-induced microvesication in hairless guinea pigs: effect of short-term niacinamide administration. Toxicol. Appl. Pharmacol. 1992, 117:104-109.
189. Yourick J.J., Dawson J.S., Mitcheltree L.W. Reduction of erythema in hairless guinea pigs after cutaneous sulfur mustard vapor exposure by pretreatment with niacinamide, promethazine and indomethacin. J. Appl. Toxicol. 1995, 15:133-138.